Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ; Comparative Efficacy Antidepressants Study Group.

CNS Drugs. 2005;19(2):137-46.

PMID:
15697327
2.
3.

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.

Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S; Mirtazapine-Venlafaxine Study Group.

J Clin Psychopharmacol. 2001 Aug;21(4):425-31.

PMID:
11476127
4.
5.
6.

Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.

Malhi GS, Ng F, Berk M.

Aust N Z J Psychiatry. 2008 Apr;42(4):346-9. doi: 10.1080/00048670701881587.

PMID:
18330778
7.

Mirtazapine compared with paroxetine in major depression.

Benkert O, Szegedi A, Kohnen R.

J Clin Psychiatry. 2000 Sep;61(9):656-63.

PMID:
11030486
8.

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.

Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM Jr; Mirtazapine vs. Paroxetine Study Group.

Am J Geriatr Psychiatry. 2002 Sep-Oct;10(5):541-50.

PMID:
12213688
9.

Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.

Winokur A, DeMartinis NA 3rd, McNally DP, Gary EM, Cormier JL, Gary KA.

J Clin Psychiatry. 2003 Oct;64(10):1224-9.

PMID:
14658972
10.
11.

Mirtazapine versus selective serotonin reuptake inhibitors.

Thompson C.

J Clin Psychiatry. 1999;60 Suppl 17:18-22; discussion 46-8. Review.

12.

Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.

Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ.

J Clin Psychopharmacol. 2006 Feb;26(1):75-8.

PMID:
16415711
13.

A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.

Høyberg OJ, Maragakis B, Mullin J, Norum D, Stordall E, Ekdahl P, Ose E, Moksnes KM, Sennef C.

Acta Psychiatr Scand. 1996 Mar;93(3):184-90.

PMID:
8739664
14.

Relationships among measures of treatment outcome in depressed patients.

Mulder RT, Joyce PR, Frampton C.

J Affect Disord. 2003 Sep;76(1-3):127-35.

PMID:
12943942
15.

A risk-benefit assessment of mirtazapine in the treatment of depression.

Kasper S, Praschak-Rieder N, Tauscher J, Wolf R.

Drug Saf. 1997 Oct;17(4):251-64. Review. Erratum in: Drug Saf 1998 Feb;18(2):123.

PMID:
9352961
16.

Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.

van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.

Int Clin Psychopharmacol. 1995 Mar;10(1):3-9.

PMID:
7622801
17.

Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.

Smith WT, Glaudin V, Panagides J, Gilvary E.

Psychopharmacol Bull. 1990;26(2):191-6.

PMID:
2236455
18.

Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.

Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H; Mirtazapine in the Nursing Home Study Group.

Curr Med Res Opin. 2003;19(8):737-46.

PMID:
14687445
19.

Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.

Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.

J Clin Psychopharmacol. 2003 Aug;23(4):358-64. Erratum in: J Clin Psychopharmacol. 2003 Dec;23(6):682.

PMID:
12920411
20.

Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.

Fava M, Dunner DL, Greist JH, Preskorn SH, Trivedi MH, Zajecka J, Cohen M.

J Clin Psychiatry. 2001 Jun;62(6):413-20.

PMID:
11465517

Supplemental Content

Support Center